Atacand and Dotarem drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Atacand (candesartan cilexetil) and Dotarem (gadoterate meglumine). Common drug interactions include cough among females.

The phase IV clinical study analyzes what interactions people have when they take Atacand and Dotarem. It is created by eHealthMe based on reports of 12 people who take the same drugs from the FDA, and is updated regularly.

What is Atacand?

Atacand has active ingredients of candesartan cilexetil. It is often used in high blood pressure. eHealthMe is studying from 22,473 Atacand users. Check the latest studies of Atacand.

What is Dotarem?

Dotarem has active ingredients of gadoterate meglumine. eHealthMe is studying from 2,749 Dotarem users. Check the latest studies of Dotarem.



On Aug, 01, 2026

12 people who take Atacand and Dotarem together, and have interactions are studied.

Atacand and Dotarem drug interactions.

What are the common drug interactions of Atacand and Dotarem, by gender? *:

female:

  1. Cough
  2. Activated partial thromboplastin time prolonged
  3. Cholelithiasis (the presence or formation of gallstones in the gallbladder or bile ducts)
  4. Creatinine renal clearance decreased
  5. Depression
  6. Dry skin
  7. Dyspnoea exertional (breathlessness or shortness of breath)
  8. Fatigue (feeling of tiredness)
  9. Gamma-glutamyltransferase increased
  10. General physical health deterioration (weak health status)

male:

n/a

What are the common drug interactions of Atacand and Dotarem, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Blood urea increased
  2. Chest discomfort
  3. Cholelithiasis (the presence or formation of gallstones in the gallbladder or bile ducts)
  4. Cough
  5. Creatinine renal clearance decreased
  6. Depression
  7. Dry skin
  8. Dyspnoea exertional (breathlessness or shortness of breath)
  9. Fatigue (feeling of tiredness)
  10. Gamma-glutamyltransferase increased

50-59:

n/a

60+:

  1. Cough
  2. Dyspnoea (difficult or laboured respiration)
  3. Urticaria (rash of round, red welts on the skin that itch intensely)

What are the existing conditions these people have? *

  1. Nausea (feeling of having an urge to vomit): 11 people, 91.67%
  2. Musculoskeletal Pain (pain affects the bones, muscles, ligaments, tendons, and nerves): 11 people, 91.67%
  3. Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 11 people, 91.67%
  4. Blood Pressure Abnormal: 11 people, 91.67%

* Approximation only. Some reports may have incomplete information.

Do you take Atacand and Dotarem?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Atacand and Dotarem:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Atacand:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Dotarem:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Atacand and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Dotarem and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on candesartan cilexetil and gadoterate meglumine (the active ingredients of Atacand and Dotarem, respectively), and Atacand and Dotarem (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: